INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 178 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $187 | +28.1% | 10,066 | -7.2% | 0.00% | 0.0% |
| Q1 2023 | $146 | +17.7% | 10,845 | +8.1% | 0.00% | 0.0% |
| Q4 2022 | $124 | -100.0% | 10,030 | +310.2% | 0.00% | -50.0% |
| Q3 2018 | $309,000 | -11.0% | 2,445 | -40.8% | 0.00% | 0.0% |
| Q2 2018 | $347,000 | +45.2% | 4,133 | +6.2% | 0.00% | 0.0% |
| Q1 2018 | $239,000 | -30.9% | 3,891 | -34.4% | 0.00% | 0.0% |
| Q4 2017 | $346,000 | +11.3% | 5,929 | +213.4% | 0.00% | 0.0% |
| Q3 2016 | $311,000 | -8.0% | 1,892 | -20.0% | 0.00% | 0.0% |
| Q2 2016 | $338,000 | +26.6% | 2,366 | +13.8% | 0.00% | 0.0% |
| Q1 2016 | $267,000 | +13.1% | 2,079 | +31.6% | 0.00% | 0.0% |
| Q4 2015 | $236,000 | -41.9% | 1,580 | -35.4% | 0.00% | -33.3% |
| Q3 2015 | $406,000 | +66.4% | 2,445 | +142.3% | 0.00% | +50.0% |
| Q2 2015 | $244,000 | +13.0% | 1,009 | +31.6% | 0.00% | 0.0% |
| Q1 2015 | $216,000 | +242.9% | 767 | +90.8% | 0.00% | – |
| Q4 2014 | $63,000 | -44.2% | 402 | -15.9% | 0.00% | -100.0% |
| Q3 2014 | $113,000 | +1.8% | 478 | +2.1% | 0.00% | 0.0% |
| Q2 2014 | $111,000 | – | 468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |